| Traditional Chinese Medicine Analysis | Lifetime | 44 | CN 36 | 99.11 |
| MicroRNA in disease regulation | Lifetime | 523 | CN 187 | 98.30 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 26 | CN 17 | 97.08 |
| Cancer-related molecular mechanisms research | Lifetime | 825 | CN 375 | 97.79 |
| Circular RNAs in diseases | Lifetime | 380 | CN 201 | 97.59 |
| Pharmacological Effects of Natural Compounds | Lifetime | 571 | CN 160 | 96.42 |
| Inflammasome and immune disorders | Lifetime | 443 | CN 36 | 96.02 |
| Natural product bioactivities and synthesis | Lifetime | 824 | CN 193 | 96.66 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 877 | CN 17 | 96.78 |
| Ginseng Biological Effects and Applications | Lifetime | 352 | CN 173 | 94.75 |
| Liver physiology and pathology | Lifetime | 712 | CN 55 | 95.12 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 553 | CN 53 | 91.15 |
| Fibroblast Growth Factor Research | Lifetime | 837 | CN 59 | 90.91 |
| Natural Compounds in Disease Treatment | Lifetime | 264 | CN 131 | 83.23 |
| Inflammation biomarkers and pathways | Lifetime | 857 | CN 148 | 70.58 |
| Inflammasome and immune disorders | 2021-2025 | 46 | CN 19 | 97.45 |
| RNA modifications and cancer | 2021-2025 | 494 | CN 331 | 95.92 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 55 | CN 4 | 93.26 |
| NF-κB Signaling Pathways | 2021-2025 | 16 | CN 6 | 90.83 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 279 | CN 59 | 87.52 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 596 | CN 32 | 91.52 |
| Receptor Mechanisms and Signaling | 2021-2025 | 393 | CN 80 | 88.33 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 217 | CN 89 | 85.43 |
| Cell Adhesion Molecules Research | 2021-2025 | 383 | CN 51 | 80.22 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 550 | CN 109 | 82.48 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 124 | CN 6 | 79.70 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 283 | CN 25 | 75.17 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 448 | CN 399 | 76.02 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 860 | CN 190 | 69.20 |
| Chemokine receptors and signaling | 2021-2025 | 441 | CN 83 | 64.77 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 937 | CN 225 | 57.93 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 567 | CN 149 | 55.96 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 801 | CN 204 | 53.53 |
